Stent for sudden heart artery tears
Part of Heart & circulation clinical trials.
This trial tests a special covered stent (a small mesh tube) for treating sudden tears in heart arteries or bypass grafts. If you have a perforation in a vessel of a certain size, this stent may help seal it and stop bleeding.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a sudden tear (perforation) in a blood vessel of your heart or a bypass graft that is 2.5 to 5.0 mm wide.
- You can safely take blood-thinning medicines (antiplatelet drugs or anticoagulants).
- You are not allergic to any materials in the stent, such as silicon carbide, polyurethane, or cobalt chromium alloy (including tungsten and nickel).
- The tear can be reached and treated with a stent.
- You do not have an untreated bleeding disorder.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a stent that slowly dissolves after opening a blocked heart artery, releasing a drug to prevent reclogging. It may help people with narrowing in one or two spots that are not too hard or twisted.
This trial compares two types of small mesh tubes (scaffolds and stents) to open blocked heart arteries. It is for people having a specific kind of heart attack or unstable angina who need a stent.
This trial tests a new stent system for treating narrowed heart arteries. If you have coronary artery disease with one or two blockages that are at least 70% narrowed, this procedure might be an option for you.
This trial compares two techniques for placing stents in the tricky area where a coronary artery splits into two branches (a bifurcation). The goal is to see which method leads to better blood flow and fewer complications for people with blockages there.
This trial tests whether implanting stents in non-obstructive, high-risk plaques (thin-capped fatty plaques) can prevent future heart attacks. It is for people who have already had treatment for a recent heart attack or unstable angina and have additional plaques that are not severely blocking blood flow but are vulnerable.
This trial studies whether a specific stent (with no polymer coating) plus a single blood thinner plan with aspirin and another P2Y12 medicine is as safe and effective as the standard two-medicine plan after a STEMI heart attack. It may help people avoid longer exposure to stronger blood-thinning if the new approach works as well.
Hear when a new Coronary Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.